Category Archives: Drug prices

The Cost of Cancer: WHO Report Says Expensive Drugs ‘Impairing’ Access to Cure

Source: NEWS18 1st Feb 2019, New Delhi A recent report by the World Health Organisation (WHO) says the standard treatment for breast cancer can drain 10 years of average annual income in India. Forty-five-year old Virendra Sharma’s father was diagnosed … Continue reading

Posted in Access to Medecines, Cancer, Drug prices, India, Patent | Leave a comment

Competition Commission Must Act on the Cartel Controlling Medical Devices

Source: The Wire 18th Jan 2019 Recently, Implant Files, a global investigation by the International Consortium of Investigative Journalists (ICIJ)  revealed the unethical use of medical devices and the nexus between companies, doctors and hospitals in 36 countries. The Indian Express investigated the … Continue reading

Posted in Drug prices | Leave a comment

People living with hepatitis C and HIV challenge evergreening patents on lifesaving hepatitis C drugs in India

New Delhi, 10 July 2018: Delhi Network of Positive People (DNP+) has filed today two patent oppositions before the Indian patent office, challenging additional patent claims by US pharmaceutical corporation-Gilead Sciences for the hepatitis C medicines sofosbuvir and velpatasvir. These … Continue reading

Posted in Drug prices, Hepatitis C, Indian Patent Law, Patent, Patent Opposition, Sec 3 (d) | Tagged , | Leave a comment

Transparency in drug pricing an important goal: Dutch health minister

By Rema Nagarajan, The Times of India | June 21, 2018 Netherlands health minister Bruno Bruins was in India recently to promote investments in life sciences and health with affordable healthcare being a key concern for both countries. Bruins spoke to the Times … Continue reading

Posted in Drug prices, Uncategorized | Leave a comment

Drug prices row: EU health chief hits back at Trump view that Europe is ‘free-loading’ on US innovation

Vytenis Andriukaitis calls ‘fake news’ on Trump drug price blame game. Tariffs on medicines – if ever proposed by the US – would be ‘a humanitarian tragedy’, he says by Éanna Kelly, Science Business Health commissioner Vytenis Andriukaitis has flatly rejected the … Continue reading

Posted in Drug prices, Uncategorized | Leave a comment

How the Government Can Lower Drug Prices

Source: The New York Times | June 20, 2018 In Baltimore, the health commissioner, Dr. Leana Wen, uses a need-based algorithm to decide which emergency rooms, needle-exchange vans, E.M.T.s and opioid outreach workers receive the city’s limited supply of naloxone — … Continue reading

Posted in Bad Pharma, Drug prices | Leave a comment

WHO: Proposed work program on “fair price” undermines affordability of medicines

Source: The Third World Network | May 21, 2018 by KM Gopakumar Geneva:  The proposed work program on fair price raises concerns on affordability of medicines. The document was prepared by the Secretariat of the World Health Organization (WHO)for the … Continue reading

Posted in Access to Medecines, Drug prices, Pricing, TRIPS, TRIPS flexibilities, Uncategorized | Leave a comment